KKR and Impilo Announce Strategic Partnership Together With Management in Rare Disease Platform Immedica Pharma

STOCKHOLM & LONDON–(BUSINESS WIRE)–Investment funds managed by KKR, a leading global investment firm, have agreed to acquire Immedica Pharma, a pharmaceutical company headquartered in Stockholm, Sweden, focused on the commercialization of medicines for rare diseases and specialty care products. Existing owner, Nordic healthcare investment firm Impilo, will reinvest to become an equal owner alongside KKR. … [Read more…]

ImmunityBio Announces FDA Approval of ANKTIVA®, First-in-Class IL-15 Receptor Agonist for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer

Designated an FDA Breakthrough Therapy, the novel immunotherapy ANKTIVA activates the body’s natural killer (NK) and killer T-cell immune system to attack tumor cells Therapy stimulates memory T cells, leading to long duration of complete response exceeding 47 months and ongoing to date, with a median duration of response yet to be determined The percentage … [Read more…]

ElevateBio Announces Presentations at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting

WALTHAM, Mass.–(BUSINESS WIRE)–ElevateBio, LLC (ElevateBio), a technology-driven company focused on powering the creation of life-transforming genetic medicines, today announced four poster presentations at the upcoming American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting taking place May 7-11, in Baltimore, MD. The poster presentations will detail ElevateBio’s expertise in optimizing the development and … [Read more…]

Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-K

CHICAGO–(BUSINESS WIRE)–Exicure, Inc. (“Exicure” or the “Company”) (Nasdaq: XCUR), announced today it received a notice of non-compliance from Nasdaq Stock Market LLC (“Nasdaq”) on April 17, 2024 notifying the Company that, as a result of the Company’s failure to timely file its Annual Report on Form 10-K for the year ended December 31, 2023 (the … [Read more…]

Canadian Pharmacies Have Access to New Automation Equipment and Software to Improve Patient Safety and Adherence

GENOA CITY, Wis.–(BUSINESS WIRE)–Canadian pharmacies serving the hospital, retail, and long-term care markets now have access to next-generation pharmacy automation technology to increase the reliability, efficiency, and safety of medication management. This includes adherence pouch packaging and inspection systems and front-loading semi-automated vial filling machines. Today’s pharmacy automation technologies help pharmacies streamline pharmacy operations, enhance … [Read more…]

Availity Appoints Sean Barrett as Chief Product Officer

JACKSONVILLE, Fla.–(BUSINESS WIRE)–Availity, the nation’s largest real-time health information network, announced the appointment of Sean Barrett as its new Chief Product Officer. With an extensive background in healthcare technology and a proven track record of driving innovation, Barrett brings valuable expertise to Availity as the company continues to revolutionize the healthcare industry. In his new … [Read more…]

Salubris Biotherapeutics Announces $35 Million in Financing and Provides Pipeline Progress Update

Shenzhen Salubris commits additional funding to continue research and development of novel, complex biologics First patient enrolled in RENEU-HF, the Phase 2 clinical trial of JK07 in heart failure with reduced ejection fraction (HFrEF) and preserved ejection fraction (HFpEF) Clinical trial application filed for JK06, SalubrisBio’s first-in-class biparatopic ADC GAITHERSBURG, Md.–(BUSINESS WIRE)–Salubris Biotherapeutics, Inc. (SalubrisBio), … [Read more…]

REPLY: Value Based Medicine Is Born, the Platform Created by Laife Reply for IEO That Makes Patient Care Increasingly Personalised and Appropriate

TURIN, Italy–(BUSINESS WIRE)–Laife Reply, a company within the Reply Group focused on using AI, Big Data and Machine Learning to innovate preventive healthcare and treatment processes has developed, in collaboration with IEO (European Institute of Oncology), the Value Based Medicine (VBM), a web platform to support the patient care cycle. The platform’s objective is to … [Read more…]

Donor Dash Brings Wyomingites Together to Celebrate the Gift of Life

Annual 5K run/walk honors, celebrates & recognizes those impacted by donation CASPER, Wyo.–(BUSINESS WIRE)–Today, Donor Alliance, the nonprofit organization that facilitates organ and tissue donation for transplantation in most of Wyoming and Colorado, hosted its annual Wyoming Donor Dash with more than 330 Wyomingites at Tate Pumphouse. Supported by Banner Wyoming Medical Center and Rocky … [Read more…]

NovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Stockholder Equity

EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that on April 18, 2024 it received a notice from the NYSE American LLC stating that the Company is below compliance with the NYSE American continued listing standards set forth in Sections 1003(a)(ii) and (iii) of the NYSE American Company Guide pursuant to stockholders equity. The … [Read more…]